News

In the challenging fiscal year 2023, the SICK Group continued to maintain a momentum of solid growth. Group turnover increased by 5.4% to 2.307 billion euros. After deducting exchange rate factors, the group's turnover even increased by 8.8% compared with the previous year. The overall financial situation and earnings are good.

In fiscal year 2023, the company invested 11.7% of its turnover in research and development. SICK continues to offer a broad, diverse and future-oriented solution portfolio to support the industrial digital transformation of customers around the world. The company submitted 70 patent applications for automation solutions based on software and AI technology in 2023, further promoting the rapid development of sensor intelligence. Currently, SICK has a total of 12,185 employees worldwide, and we will always move forward side by side with you.

SICK not only performed well but also successfully achieved its goals. Revenue increased by 5.4% to 2.307 billion euros. Earnings before interest and taxes (EBIT) increased by 15.1% compared with the previous year to €189 million.

"FY2023 was full of challenges, but we were still able to achieve growth in turnover and profits, and we are very proud of the results we have achieved. More than 12,000 employees at SICK around the world are full of passion and work tirelessly to develop new solutions for customers, aiming to Rapidly adapting to market dynamics and making technological progress, despite the challenges that come one after another, the good business development situation in fiscal 2023 encourages us to work closely with customers and partners to jointly build industrial digitalization,” said Dr. Mats Gökstorp, Chairman of the Board of Directors of SICK AG. .

The salient features of fiscal year 2023 are the spread of geopolitical conflicts, the slowdown in global economic development momentum, more stringent financing conditions, high inflation rates and benchmark interest rates, which in turn lead to restrictions on investment.

"In addition to turnover and profit, our profitability has also improved. EBIT increased to 8.2% from 7.5% in the previous year. This reflects SICK's successful balance between short-term profitability and long-term technical support," explains Jan-H. Eberhardt, Member of the Executive Board of SICK AG.

As of December 31, 2023, SICK had a total of 12,185 employees, an increase of 2.3% compared to the previous year. The focus of personnel growth is in the area of research and development. Headcount increased by 9.2% to 1,760.

Innovative ideas in research and development have been transformed into specific products that meet market needs, and SICK has applied for 137 patents. Software-based solutions have been awarded 70 patents and are embedding artificial intelligence into SICK sensor hardware in an increasing number of applications. The company holds nearly 4,000 technology solution patents around the world, providing support to customer companies in digital control and automated industrial processes.

Although short-term indicators of economic conditions are bleak in the first quarter of 2024, and a sustained recovery is not expected until late 2024, sensing technology will remain an important growth market now and in the future.

"Like many industrial companies, SICK is starting the new fiscal year with cautious optimism and the necessary awareness of cost control. With our efficient portfolio of industrial digital solutions and the dedication of our employees and teams around the world, we are convinced that we will be able to The ideal way to meet the current and future development requirements of our customers,” says Dr. Mats Gökstorp, Chairman of the Board of Directors of SICK.